首页> 外文期刊>Psychiatry and Clinical Psychopharmacology >New Psycho-Active Substances: The Legal Procedure Used in European Union Countries and Turkey
【24h】

New Psycho-Active Substances: The Legal Procedure Used in European Union Countries and Turkey

机译:新的精神活性物质:欧盟国家和土耳其使用的法律程序

获取原文
           

摘要

New psycho-active substances have recently begun to be substituted for narcotics as drugs of abuse. The main reason for this situation is that they are not included in the controlled substance list, despite the fact that they cause psychoactive effects, resulting in their purchase and use without fear of penalty.It has been observed, in recent years, that some psychoactive substances have been traded under the street names of ‘herbal drugs,’ or ‘spices’ implying that they are harmless and leading to misinformation about their true content. There are some expressions such as ‘incense’ or ‘nonhuman consumption’ on their packets and they are sold by ‘smart shops,’ ‘head shops’ and/or web sites.The EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) is a European Union (EU) decentralised organisation which has been established to provide science-based information, policy making, coordination, and cooperation among the professionals working in the field of illicit drug use and trafficking. The EWS (Early Warning System) as a subunit of the EMCDDA is an effective means of fast and effective communication among the EU countries. A total of 114 new psychoactive substances have been reported through the system since 1997, and the 24 of them were identified in 2009.The EMCDDA has National Focal Points (NFPs) set up in the 27 EU Member States, and in candidate countries such as Turkey and Croatia. The National Focal Point of Turkey is the Turkish Monitoring Centre for Drugs and Drug Addiction (TUBIM).If the EMCDDA decides to bring under its control a new psychoactive substance that has social risks identified by scientific evaluation, the decision is declared and must become effective in all member states by a specific deadline. BZP (Benzylpiperazine) and mCPP (metachlorophenylpiperazine) were the last two substances to have been placed on the control list by the EMCDDA.Due to ‘universal principle of legality’ no one shall be held guilty of possession, use or trafficking of a new psychoactive substance that has not yet been listed as a controlled substance under national or international law. Different procedures are used for adding substances to the controlled lists. There are three kind of classifications used by countries. Generally, countries list the chemical names of controlled substances individually in the national legislation. Legal sanctions are applied only if the substance that has been seized is chemically equivalent to a substance on the list. The generic system refers to the inclusion, usually within the list, of the individual substances under control, and of a precise definition of a group of substances. In the context of the current study, this is over and above the isomers, esters, ethers and salts. The analogue system addresses more general aspects of similarity in the chemical structure of a controlled substance; this aspect might be supplemented by a requirement for similarity in pharmacological activity such as stimulant, depressant, or hallucinogenic effects.Standard procedure is the common way to add a new psychoactive substance to the controlled substances list. This procedure begins with the notification of the Ministry of Health about the new psychoactive substance and continues by scientific evaluation. If the evaluation results in a recommendation for the substance to be banned, a proposal for approval is usually presented to the Council of Ministers or alternatively to the Parliament and/or the Senate.Due to the fact that standard procedure can take a long time, some countries may use rapid or emergency procedures. The basic difference between them is that the rapid procedure is permanent, whereas the emergency procedure is temporary until the standard procedure is completed.If the implementation of the legal procedure for banning a new psychoactive substances is delayed, only drug traffickers benefit. A decrease in the illicit market is expected as a result of listing of a new psychoactive substance in the controlled substance list.?ZETGünümüzde narkotik maddelerin yerini yeni psiko-aktif maddeler almaya ba?lam??t?r. Bu durumun temel sebebi psiko-aktif etki do?urmalar?na ra?men henüz yasak maddeler listelerinde yer almamalar? nedeni ile cezai yapt?r?m korkusu olmaks?z?n kullan?m?n?n ve ticaretinin yap?labilmesidir.Son y?llarda baz? psiko-aktif maddelerin ‘herbal drugs’, ‘baharat kar???m?’ gibi adlar alt?nda, zararl? etkilerinin bulunmad??? s?ylenerek sat??a sunuldu?u g?rülmektedir. Bu maddelerin paketleri üzerinde ‘ho? kokulu tütsü’, ‘insan tüketimi i?in de?ildir’ gibi ibareler bulunmakta ve 'smart shop; ‘head shop’ ad? verilen dükkanlar ve/veya internet siteleri arac?l??? ile sat?? ger?ekle?tirilmektedir.EMCDDA (European Monitoring Centre for Drugs and Drug Addiction-Avrupa Uyu?turucu ve Uyu?turucu Ba??ml?l??? ?zleme Merkezi) Avrupa Birli?i'ne ba?l? ve temel faaliyet alan? uyu?turucu madde ve madde ba??ml?l??? ile mücadele eden profesyoneller aras?nda koordinasyon ve koop
机译:新的精神活性物质最近已开始替代麻醉药品,成为滥用药物。造成这种情况的主要原因是,尽管它们会引起精神活性,从而导致其购买和使用而不必担心受到惩罚,但它们仍未列入受控物质清单中。近年来已观察到一些精神活性物质这些物质已经以“草药”或“香料”的街头名称进行交易,这意味着它们是无害的,并导致对其真实含量的误解。包装上有诸如“香”或“非人类消费”之类的表述,它们通过“智能商店”,“总店”和/或网站出售。EMCDDA(欧洲毒品和毒瘾监测中心)是欧洲联盟(EU)的分散组织,其成立是为了在从事非法药物使用和贩运领域的专业人员之间提供基于科学的信息,政策制定,协调与合作。 EWS(预警系统)作为EMCDDA的一个子单位,是欧盟国家之间快速有效沟通的有效手段。自1997年以来,通过该系统共报告了114种新的精神活性物质,其中24种在2009年被鉴定出来.EMCDDA在27个欧盟成员国以及候选国家中设立了国家归口单位(NFP)。土耳其和克罗地亚。土耳其国家联络点是土耳其毒品与毒品成瘾监测中心(TUBIM)如果EMCDDA决定将一种具有科学评估确定的社会风险的新型精神活性物质置于控制之下,则该决定将宣布并必须生效在特定的截止日期之前在所有成员国。 BZP(苄基哌嗪)和mCPP(间氯苯基哌嗪)是EMCDDA列入控制清单的最后两种物质,由于``普遍合法性''原则,任何人不得被视为拥有,使用或贩运一种新的精神活性物质。尚未被国家或国际法列为受控物质的物质。使用不同的程序将物质添加到受控列表中。国家使用三种分类。通常,国家/地区在国家法规中单独列出受控物质的化学名称。仅当所缉获的物质在化学上等同于清单中的物质时,才适用法律制裁。通用系统是指通常在列表中包括受控制的单个物质,以及一组物质的精确定义。在本研究的范围内,这是异构体,酯,醚和盐的基础。该模拟系统解决了受控物质化学结构相似性的更多一般性方面。在这方面可能需要对药理活性具有相似性的要求进行补充,例如刺激,抑制或致幻作用。标准程序是将新的精神活性物质添加到受控物质列表中的常用方法。该程序始于卫生部关于新精神活性物质的通知,并通过科学评估继续进行。如果评估结果提出了关于应禁止使用该物质的建议,通常会向部长会议或国会和/或参议院提出批准提案。由于标准程序可能需要很长时间,一些国家可能会使用快速或紧急程序。它们之间的基本区别是快速程序是永久程序,而紧急程序是临时程序,直到标准程序完成为止。如果禁止新的精神活性物质的法律程序的执行被推迟,则只有贩毒者才能受益。由于将新的精神活性物质列入管制物质清单,预计非法市场将减少。ZETGünümüzdenarkotik maddelerin yerini yeni psiko-aktif maddeler almaya ba?lam ?? t?r。 Bu durumun temel sebebi psiko-aktif etki do?urmalar?na ra?menhenüzyasak maddeler listelerinde yer almamalar? nedeni ile cezai yapt?r?m korkusu olmaks?z?n kullan?m?n?n tic ticaretinin yap?labilmesidir.Son y?llarda baz? psiko-aktif maddelerin“草药”,“ baharat kar ??? m?” gibi adlar alt?nda,zararl? etkilerinin bulunmad ??? s?ylenerek坐在一个sunuldu?u g?rülmektedir。 Bu maddelerin paketleriüzerinde‘何? kokulutütsü’,‘insantüketimii?in de?ildir’gibi ibareler bulunmakta ve的“智能商店”; “头店”广告? verilendükkanlarve / veya Internet siteleri arac?l ???我坐吗? ger?ekle?tirilmektedir.EMCDDA(欧洲药物和药物成瘾监测中心-Avrupa Uyu?turucu ve Uyu?turucu Ba?ml?l ????zleme Merkezi)Avrupa Birli?i'ne ba?l? ve temel faaliyet阿兰? uyu?turucu madde ve madde ba ?? ml?l ??? ilemücadeleeden profesyoneller aras?nda koordinasyon ve koop

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号